LH

Labcorp Holdings Inc

328.95

Oct 23 • 3:59 PM ET -0.98 (-0.30%)

328.95

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Diagnostics & Research USA Large NYSE

Oct 23, 8:05 AMLabcorp partners with Waters to roll out FDA-approved BD Onclarity HPV Assay nationwide starting in late 2026

Peers: DGX ICLR CRL IQV MEDP NTRA TMO GH NEO FTRE

| Held by: VTI VOO VO IVV SPY VTV RSP XLV VOE IWR

Scroll to Statements

Index	S&P 500
Market Cap	26.68B
Enterprise Value	33.32B
Income	1.00B
Sales	14.35B
Book/sh	106.39
Cash/sh	1.75
Dividend Est.	2.95 (0.90%)
Dividend TTM	2.88 (0.88%)
Dividend Ex-Date	Nov 24, 2026
Dividend Gr. 3/5Y	10.06% -
Payout	27.54%
Employees	71000
IPO	Jul 07, 1988

P/E	27.20
Forward P/E	16.59
PEG	1.74
P/S	1.86
P/B	3.09
P/C	188.14
P/FCF	23.09
EV/EBITDA	14.33
EV/Sales	2.32
Quick Ratio	1.53
Current Ratio	1.80
Debt/Eq	0.79
LT Debt/Eq	0.76
Option/Short	Yes / Yes

EPS (ttm)	12.09
EPS next Y	19.83
EPS next Q	4.64
EPS this Y	11.63%
EPS next Y	8.05%
EPS next 5Y	9.53%
EPS past 3/5Y	-9.18% -8.01%
Sales past 3/5Y	5.55% -0.04%
EPS Y/Y TTM	33.31%
Sales Y/Y TTM	6.41%
EPS Q/Q	28.47%
Sales Q/Q	5.78%
Earnings	Oct 28 BMO
EPS/Sales Surpr.	4.41% 0.59%

Insider Own	0.40%
Insider Trans	-4.98%
Inst Own	100.73%
Inst Trans	-0.04%
ROA	5.48%
ROE	11.74%
ROIC	6.60%
Gross Margin	26.82%
Oper. Margin	11.35%
Profit Margin	6.99%
SMA20	4.22%
SMA50	2.56%
SMA200	15.36%
Trades

Shs Outstand	80.90M
Shs Float	80.77M
Short Float	3.32%
Short Ratio	3.67
Short Interest	2.68M
52W High	341.80 -3.76%
52W Low	244.52 34.53%
Volatility	2.57% 2.09%
ATR (14)	7.49
RSI (14)	62.75
Beta	0.89
Rel Volume	0.91
Avg Volume	732.17K
Volume	664,233

Perf Week	3.46%
Perf Month	6.47%
Perf Quarter	9.22%
Perf Half Y	24.70%
Perf YTD	31.12%
Perf Year	15.83%
Perf 3Y	66.20%
Perf 5Y	35.71%
Perf 10Y	175.95%
Recom	1.71
Target Price	348.60
Prev Close	329.93
Price	328.95
Change %	-0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-25	Downgrade	HSBC Securities	Buy → Hold	$260
Apr-02-25	Initiated	Redburn Atlantic	Buy	$276
Mar-04-25	Upgrade	Citigroup	Neutral → Buy	$250 → $300
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform	$260 → $265
Dec-10-24	Resumed	Jefferies	Buy	$265 → $275
Oct-30-24	Upgrade	HSBC Securities	Hold → Buy
Oct-01-24	Initiated	Piper Sandler	Neutral	$235
Mar-25-24	Upgrade	Argus	Hold → Buy	$250
Feb-26-24	Initiated	Leerink Partners	Outperform	$260
Feb-09-24	Initiated	Evercore ISI	In-line	$240
Jan-03-24	Initiated	Barclays	Equal Weight	$222
Sep-06-23	Initiated	HSBC Securities	Hold	$210
Dec-12-22	Downgrade	Citigroup	Buy → Neutral	$275 → $250
Sep-19-22	Downgrade	Argus	Buy → Hold
Aug-22-22	Resumed	Morgan Stanley	Overweight	$300
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold	$330 → $294
Jan-11-21	Upgrade	Argus	Hold → Buy	$245
Jan-11-21	Downgrade	Wolfe Research	Peer Perform → Underperform
Jan-08-21	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-14-20	Upgrade	BofA Securities	Neutral → Buy	$194 → $220

Show Previous Ratings

Oct-23-26 08:00AM	Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 (PR Newswire)
Oct-22-26 04:30PM	Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential (PR Newswire)
Oct-21-26 06:50AM	Labcorp Declares Quarterly Dividend (PR Newswire)
Oct-20-26 11:45AM	Myriad Genetics stock surges on $210M prenatal unit sale (Investing.com)
Oct-15-26 09:45AM	Opko Health stock soars on $722M BioReference asset sale (Investing.com)
07:30AM	Loading…
07:30AM	Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health (PR Newswire)
Oct-13-26 08:00AM	Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test (PR Newswire)
Oct-12-26 06:53PM	Should You Trim Or Add To Your Hims & Hers Position Now? (Trefis)
Oct-08-26 05:39PM	Is Hims & Hers Stock Ready For A Longer Cash Burn? (Trefis)
Sep-30-26 08:30AM	Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026 (PR Newswire)
Sep-22-26 07:55AM	Premarket movers: Quest, Labcorp hit by CMS cuts (Investing.com)
Sep-10-26 04:30PM	Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors (MarketWatch)
07:00AM	Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day (PR Newswire)
Sep-09-26 08:55AM	Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update (PR Newswire)
Sep-08-26 09:05AM	Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials (PR Newswire)
03:29PM	Loading…
Aug-31-26 03:29PM	Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest (Trefis)
07:00AM	Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity (PR Newswire)
Aug-28-26 08:30AM	Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference (PR Newswire)
Aug-24-26 07:02AM	Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings (PR Newswire)
Aug-20-26 03:21PM	Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash (Trefis)
Aug-18-26 07:00AM	Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health (PR Newswire)
Aug-17-26 08:00AM	Labcorp to Host Investor Day on September 10, 2026 (PR Newswire)
Aug-10-26 07:00AM	Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma (PR Newswire)
Aug-04-26 07:00AM	Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer (PR Newswire)
Jul-30-26 05:38PM	Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy? (Trefis)
05:08PM	Labcorp Holdings Inc (LH) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... (GuruFocus.com)
06:58AM	Labcorp: Q2 Earnings Snapshot (Associated Press)
06:50AM	Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance (PR Newswire)
Jul-27-26 08:00AM	Labcorp Launches Marker by Labcorp Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing (PR Newswire)
Jul-09-26 05:05PM	Labcorp Declares Quarterly Dividend (PR Newswire)
04:15PM	Loading…
Jun-30-26 04:15PM	Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 (PR Newswire)
Jun-22-26 07:00AM	Labcorp Announces Nationwide Availability of ColoSense, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test (PR Newswire)
May-29-26 07:19AM	The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy? (MarketWatch)
07:00AM	Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer (PR Newswire)
May-28-26 07:00AM	Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects (PR Newswire)
May-27-26 08:00AM	Labcorp to Present at the Jefferies Global Healthcare Conference (PR Newswire)
May-20-26 07:00AM	Labcorp Launches MyLabcorp, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time (PR Newswire)
May-14-26 06:00AM	Labcorp expands Epic pact to make full test menu available on Aura (MedTech Dive)
May-12-26 07:00AM	Labcorp and Epic Expand Collaboration to Advance Diagnostic Integration across Hospitals and Health Systems (PR Newswire)
Apr-30-26 07:00AM	Labcorp: Q1 Earnings Snapshot (Associated Press)
06:50AM	Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance (PR Newswire)
Apr-24-26 08:00AM	SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio (TMX Newsfile)
Apr-22-26 07:00AM	Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA (PR Newswire)
Apr-15-26 07:00AM	Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes (PR Newswire)
Apr-14-26 07:00AM	Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research (PR Newswire)
Apr-13-26 08:30AM	Children's Hospital of Philadelphia and Labcorp Announce a Collaboration to Accelerate Access to Advanced Pediatric Diagnostics Nationwide (PR Newswire)
Apr-09-26 06:50AM	Labcorp Declares Quarterly Dividend (PR Newswire)
Mar-31-26 04:15PM	Labcorp to Announce First Quarter Financial Results on April 30, 2026 (PR Newswire)
Mar-23-26 06:00AM	Labcorp closes purchase of New York pathology reference lab assets (MedTech Dive)
Mar-18-26 09:15AM	Illumina and Labcorp expand collaboration to broaden access to precision oncology testing (PR Newswire)
Mar-09-26 08:25AM	Q4 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
Mar-06-26 09:40AM	Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
07:00AM	Middleby Appoints Glenn Eisenberg To Board of Directors (Business Wire)
Mar-04-26 08:14AM	Is This the Right Time to Hold Labcorp Stock in Your Portfolio? (Zacks)
Feb-27-26 12:44PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
01:12AM	OPKO Health Q4 Earnings Call Highlights (MarketBeat)
Feb-24-26 11:31PM	Labcorp expands PathAI pact to roll out digital pathology platform in US (MedTech Dive)
12:33AM	The 5 Most Interesting Analyst Questions From Labcorp's Q4 Earnings Call (StockStory)
Feb-23-26 07:00AM	Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide (PR Newswire)
Feb-19-26 09:50AM	Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term (Zacks)
07:21AM	Labcorp Holdings Stock: Is Wall Street Bullish or Bearish? (Barchart)
Feb-18-26 02:34PM	Analyst Report: Labcorp Holdings Inc. (Morningstar Research)
09:40AM	Here's Why Labcorp Holdings (LH) is a Strong Value Stock (Zacks)
12:32AM	LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges (StockStory)
Feb-17-26 04:00PM	Labcorp Holdings Inc (LH) Q4 2025 Earnings Call Highlights: Strong Revenue and EPS Growth Amid ... (GuruFocus.com)
02:00PM	Why Labcorp (LH) Shares Are Trading Lower Today (StockStory)
01:46PM	Labcorp Q4 Earnings Call Highlights (MarketBeat)
11:11AM	Pre-Markets in Red to Start Holiday Shortened Week (Zacks)
10:35AM	Pre-Markets Begins Shorter Week Slowly (Zacks)
10:07AM	Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market (Zacks)
09:30AM	Labcorp (LH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	Labcorp Holdings (LH) Q4 Earnings Surpass Estimates (Zacks)
07:09AM	Labcorp: Q4 Earnings Snapshot (Associated Press Finance)
07:01AM	Labcorp (NYSE:LH) Misses Q4 CY2025 Sales Expectations (StockStory)
06:50AM	Labcorp Announces 2025 Fourth Quarter and Full Year Results (PR Newswire)
Feb-15-26 10:07PM	Labcorp (LH) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-13-26 08:29PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Feb-11-26 12:10PM	Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:00AM	Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:15AM	Stay Ahead of the Game With Labcorp (LH) Q4 Earnings: Wall Street's Insights on Key Metrics (Zacks)
07:00AM	Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care (PR Newswire)
Feb-10-26 09:20PM	Labcorp closes takeover of Empire City assets to fuel New York expansion (MedTech Dive)
08:57AM	Labcorp's Q4 Earnings Preview: What's in Store for the Stock? (Zacks)
Feb-09-26 01:54PM	Analyst Report: Labcorp Holdings Inc. (Morningstar Research)
08:30AM	Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors (PR Newswire)
Feb-05-26 07:38PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Feb-03-26 08:10AM	Investor Concerns Impacted Labcorp (LH) in Q4 (Insider Monkey)
Jan-26-26 09:40AM	How TEM Is Capitalizing on AI-Driven Pathology Market Growth (Zacks)
Jan-21-26 08:30AM	Sorry, 'Dr. Google.' ChatGPT and Claude are now getting into the business of providing health advice. (MarketWatch)
Jan-15-26 04:34PM	These charts show the stock market giving investors a lot to like - for now - as the S&P 500 nears 7,000 (MarketWatch)
04:15PM	Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 (PR Newswire)
Jan-14-26 06:50AM	Labcorp Declares Quarterly Dividend (PR Newswire)
Jan-13-26 07:00AM	Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk (PR Newswire)
Jan-09-26 02:24PM	Clinical Labs Hope to Head Off Looming Medicare Cuts (Barrons.com)
08:09AM	Labcorps Quarterly Earnings Preview: What You Need to Know (Barchart)
06:03AM	NAMSA acquires Labcorps medical device testing assets (Medical Device Network)
Jan-08-26 09:00AM	Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs (Business Wire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ANDERSON KERRII B	Director	Aug 17 '26	Sale	318.02	3,000	954,060	6,563	Aug 18 08:10 AM
KERRII B ANDERSON	Director	Aug 17 '26	Proposed Sale	318.13	3,000	954,390		Aug 17 04:31 PM
Schechter Adam H	President & CEO	Aug 11 '26	Sale	320.37	4,669	1,495,808	102,565	Aug 12 02:31 PM
Schechter Adam H	Officer	Aug 11 '26	Proposed Sale	320.37	4,669	1,495,808		Aug 11 10:06 AM
Summy Amy B.	EVP, Chief Marketing Officer	Aug 04 '26	Sale	306.74	924	283,428	6,956	Aug 06 08:26 AM
Wilkinson Peter J	SVP, Chief Accounting Officer	Aug 03 '26	Option Exercise	209.25	1,338	279,976	3,108	Aug 05 11:17 AM
Wilkinson Peter J	SVP, Chief Accounting Officer	Aug 03 '26	Sale	309.23	1,420	439,107	1,770	Aug 05 11:17 AM
Summy Amy B.	Officer	Aug 04 '26	Proposed Sale	306.74	924	283,428		Aug 04 11:58 AM
Kyle Kathryn W	EVP, Chief Legal Officer	Jul 02 '26	Sale	286.19	92	26,329	3,904	Jul 06 09:37 AM
Vaughn Bryan T	EVP and President, Diagnostics	Jul 02 '26	Sale	286.19	234	66,968	6,746	Jul 06 09:36 AM
Kyle Kathryn W	Officer	Jul 02 '26	Proposed Sale	286.19	92	26,329		Jul 02 12:19 PM
Vaughn Bryan T	Officer	Jul 02 '26	Proposed Sale	286.19	234	66,968		Jul 02 10:29 AM
van der Vaart Sandra D	Former Officer	Jul 01 '26	Proposed Sale	280.48	7,138	2,002,066		Jul 01 10:03 AM
Kyle Kathryn W	EVP, Chief Legal Officer	Jun 08 '26	Sale	263.89	762	201,084	3,813	Jun 10 09:01 AM
Kyle Kathryn W	Officer	Jun 08 '26	Proposed Sale	263.89	762	201,084		Jun 08 12:19 PM
Schechter Adam H	President & CEO	May 11 '26	Sale	254.50	5,903	1,502,314	107,234	May 13 09:30 AM
Schechter Adam H	Officer	May 11 '26	Proposed Sale	254.50	5,903	1,502,314		May 11 09:51 AM
van der Vaart Sandra D	Former Officer	May 06 '26	Proposed Sale	256.76	6,238	1,601,649		May 06 10:40 AM
Wilkinson Peter J	SVP, Chief Accounting Officer	Mar 27 '26	Sale	267.05	1,633	436,093	1,852	Mar 30 12:54 PM
Meltzer Jonathan C	EVP, Operations	Mar 27 '26	Sale	267.05	839	224,055	3,620	Mar 30 12:44 PM
Meltzer Jonathan C	Officer	Mar 27 '26	Proposed Sale	267.05	839	224,055		Mar 27 10:40 AM
Schechter Adam H	President & CEO	Mar 03 '26	Sale	279.96	8,705	2,437,047	80,773	Mar 05 08:57 AM
Schechter Adam H	Officer	Mar 03 '26	Proposed Sale	279.96	8,705	2,437,047		Mar 03 12:23 PM
van der Vaart Sandra D	EVP, Corporate Affairs	Feb 27 '26	Sale	284.91	548	156,000	2,579	Mar 03 10:41 AM
van der Vaart Sandra D	Officer	Feb 27 '26	Proposed Sale	284.67	548	156,000		Feb 27 09:40 AM
Caveney Brian J	EVP, Pres of ED, CMO & CSO	Feb 24 '26	Sale	286.31	1,500	429,458	30,107	Feb 26 08:25 AM
Caveney Brian J	Officer	Feb 24 '26	Proposed Sale	286.31	1,500	429,458		Feb 24 01:50 PM
Wilkinson Peter J	SVP, Chief Accounting Officer	Feb 19 '26	Sale	277.94	666	185,108	1,852	Feb 23 09:13 AM
Schechter Adam H	President & CEO	Feb 11 '26	Sale	284.38	5,273	1,499,536	87,343	Feb 13 01:13 PM
Meltzer Jonathan C	EVP, Operations	Feb 12 '26	Sale	290.42	87	25,267	2,782	Feb 13 01:11 PM
Meltzer Jonathan C	EVP, Operations	Feb 10 '26	Sale	276.79	91	25,188	2,696	Feb 12 03:44 PM
Meltzer Jonathan C	Officer	Feb 12 '26	Proposed Sale	290.42	87	25,267		Feb 12 09:49 AM
Schechter Adam H	Officer	Feb 11 '26	Proposed Sale	284.38	5,273	1,499,536		Feb 11 12:59 PM
Meltzer Jonathan C	EVP, Operations	Feb 09 '26	Sale	275.53	88	24,247	2,869	Feb 10 03:04 PM
Meltzer Jonathan C	Officer	Feb 10 '26	Proposed Sale	276.79	91	25,188		Feb 10 10:30 AM
Meltzer Jonathan C	Officer	Feb 09 '26	Proposed Sale	275.53	88	24,247		Feb 09 01:30 PM
Schechter Adam H	President & CEO	Nov 11 '25	Sale	262.75	5,745	1,509,499	87,574	Nov 13 08:47 AM
Schechter Adam H	Officer	Nov 11 '25	Proposed Sale	262.75	5,745	1,509,499		Nov 12 06:54 AM
Parham Richelle P	Director	Oct 31 '25	Sale	254.28	7,009	1,782,273	2,469	Nov 04 10:28 AM
Parham Richelle P	Director	Oct 31 '25	Proposed Sale	254.28	7,009	1,782,273		Oct 31 03:16 PM

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates through the Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS) segments. The Dx segment includes routine and specialty esoteric testing. The BLS segment consists of central laboratory and ED businesses. The company was founded in 1995 and is headquartered in Burlington, NC.

PresidentMr. Adam H. Schechter

CFO & Executive VPMs. Julia A. Wang

M.D.Dr. Brian J. Caveney J.D.

EVP & Chief Operations OfficerMr. Jonathan C. Meltzer Ph.D.

Senior VP & Chief Accounting OfficerMr. Peter J. Wilkinson

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LH

Labcorp Holdings Inc

Upgrade your Finviz experience